QUALITY OF LIFE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS

被引:0
|
作者
Machate, N. [1 ]
Alchalby, H. [1 ]
Zabelina, T. [1 ]
Wulf, G. [2 ]
Sehner, S. [1 ]
Wolff, D. [3 ]
Kobbe, G. [4 ]
Bornhaeuser, M. [5 ]
Baurmann, H. [6 ]
Bethge, W. [7 ]
Zander, A. [1 ]
Kroeger, N. [1 ]
机构
[1] Univ Hamburg Hosp, Hamburg, Germany
[2] Univ Hosp, Gottingen, Germany
[3] Univ Hosp, Regensburg, Germany
[4] Univ Hosp, Dusseldorf, Germany
[5] Univ Hosp, Dresden, Germany
[6] DKD Clin, Wiesbaden, Germany
[7] Univ Hosp, Tubingen, Germany
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
PH-O058
引用
收藏
页码:S31 / S32
页数:2
相关论文
共 50 条
  • [41] Allogeneic stem cell transplantation for myelofibrosis patients aged ≥65 years
    Daghia, Giulia
    Zabelina, Tatjana
    Zeck, Gaby
    von Pein, Ute-Marie
    Christopeit, Maximilian
    Wolschke, Christine
    Ayuk, Francis
    Kroeger, Nicolaus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (04) : 370 - 378
  • [42] Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis
    H. Joachim Deeg
    Philippe Guardiola
    International Journal of Hematology, 2002, 76 : 29 - 34
  • [43] The outcome of allogeneic hematopoietic stem cell transplantation for patients with primary myelofibrosis
    Sun, K.
    Tsai, X. C. -H.
    Liu, J. -H.
    Hsu, S. -C.
    Chou, W. -C.
    Liao, X. -W.
    Hou, H. -A.
    Ko, B. -S.
    Tien, H. -F.
    Tang, J. -L.
    Yao, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 161 - 161
  • [44] Prospective assessment of quality of life (QOL) after allogeneic stem cell transplantation
    Kondo, S
    Kikuchi, K
    Yashima, T
    Nishihira, M
    Inaba, I
    Mori, T
    Watanabe, R
    Okamoto, S
    BONE MARROW TRANSPLANTATION, 2002, 29 : S263 - S263
  • [45] Quality of life after allogeneic stem cell transplantation: prospective study of predictors of impaired quality of life
    Kondo, S
    Nishihira, M
    Mori, T
    Hirooka, Y
    Yashima, T
    Kiuchi, K
    Shimura, Y
    Takeno, H
    Okamoto, S
    BONE MARROW TRANSPLANTATION, 2003, 31 : S285 - S286
  • [46] Patients' quality of life after allogeneic haematopoietic stem cell transplantation: mixed-methods study
    Niederbacher, S.
    Them, C.
    Pinna, A.
    Vittadello, F.
    Mantovan, F.
    EUROPEAN JOURNAL OF CANCER CARE, 2012, 21 (04) : 548 - 559
  • [47] Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation
    Chiusolo, Patrizia
    Orlando, Nicoletta
    Giammarco, Sabrina
    Rossi, Monica
    Metafuni, Elisabetta
    Leotta, Salvatore
    Milone, Giuseppe
    Valentini, Caterina Giovanna
    Bianchi, Maria
    Frioni, Filippo
    Pellegrino, Claudio
    Sora, Federica
    Larocca, Luigi Maria
    Sica, Simona
    Bacigalupo, Andrea
    Teofili, Luciana
    HAEMATOLOGICA, 2023, 108 (01) : 278 - 282
  • [48] Few mutational changes in myelofibrosis at relapse after allogeneic stem cell transplantation
    Christopeit, M.
    Badbaran, A.
    Alawi, M.
    Flach, J.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 93 - 93
  • [49] Effects of rehabilitation on quality of life in patients undergoing allogeneic stem cell transplantation
    Kondo, S
    Iwaori, K
    Inui, M
    Kaneko, H
    Kudo, M
    Okuwaki, S
    Mori, T
    Okamoto, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S285 - S285
  • [50] Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis
    Atagunduz, Isik Kaygusuz
    Christopeit, Maximilian
    Ayuk, Francis
    Zeck, Gaby
    Wolschke, Christine
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (12) : 2279 - 2284